The Integrated Microscopy Facility (IMF) functions as a supervised, user-based Core providing state-of-the-art microscopy imaging capabilities to University of Chicago Medicine Comprehensive Cancer Center (UCCCC) members and other University investigators. Light microscopy is an essential technology for cancer investigators. Modern microscopy enables observation of ever-finer detail, now breaking the optical diffraction barrier to yield super-resolution detail, thus providing information at scales ranging from tens of millimeters to less than 10 nanometers. The IMF offers all major wide-field and confocal techniques in addition to super- resolution technologies (e.g., stimulated emission depletion (STED), localization, structured light), and works to advance these methodologies for application to cancer research. Specific IMF developments in the current funding period include significant upgrades to microscope technologies and data analysis tools. Notably, these include installation of GSD super-resolution, a Lightsheet.z1 system, a SP8 white-light-laser spectral confocal, additional high-end workstations and upgrade to full-feature Imaris software. IMF staff additionally provides equipment maintenance, user training, and expert advice. Budgets reflect strictly a cost-recovery operation, with all services provided ?at-cost?. As an integrated Core, IMF allows for efficient pooling of resources and management, while creating a large user base that aids in leveraging support from the University as well as other agencies and keeping costs low. Half of the IMF usage is associated with research conducted by UCCCC members. Specifically, UCCCC labs are major users of the IMF; for any given service that approaches capacity usage, every effort is made to ensure priority access for UCCCC investigators. Institutional support mechanisms significantly enhance UCCCC research efforts within the IMF. The Biological Science Division (BSD) invested $1,001,408 in the Core in 2016 alone to purchase equipment requested by UCCCC members. The Core supported the work of 99 UCCCC investigators in the current funding period (2013-2016), which included 647 individual users of IMF services.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-45
Application #
9904509
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Shafik, Hasnaa
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Trujillo, Jonathan A; Sweis, Randy F; Bao, Riyue et al. (2018) T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer Immunol Res 6:990-1000
Zeng, Zongyue; Huang, Bo; Huang, Shifeng et al. (2018) The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis 5:62-74
Lee, Ji-Hye; Park, Beom Seok; Han, Kang R et al. (2018) Insight Into the Interaction Between RNA Polymerase and VPg for Murine Norovirus Replication. Front Microbiol 9:1466
Cheng, Jason X; Chen, Li; Li, Yuan et al. (2018) RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun 9:1163
Johnson, Marianna B; Hoffmann, Joscelyn N; You, Hannah M et al. (2018) Psychosocial Stress Exposure Disrupts Mammary Gland Development. J Mammary Gland Biol Neoplasia 23:59-73
Sweis, Randy F; Zha, Yuanyuan; Pass, Lomax et al. (2018) Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer. J Immunother Cancer 6:24
Kathayat, Rahul S; Cao, Yang; Elvira, Pablo D et al. (2018) Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes. Nat Commun 9:334
Liu, Jun; Eckert, Mark A; Harada, Bryan T et al. (2018) m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074-1083
Bhanvadia, Raj R; VanOpstall, Calvin; Brechka, Hannah et al. (2018) MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res 24:3668-3680
Wood, Kevin; Byron, Elizabeth; Janisch, Linda et al. (2018) Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol 41:963-966

Showing the most recent 10 out of 668 publications